MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
Go back to MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.93 +0.04 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.89 | 52 Week High | $2.51 | |||
| Open | $3.86 | 52 Week Low | $0.41 | |||
| Day High | $3.94 | P/E | N/A | |||
| Day Low | $3.86 | EPS | $-0.64 | |||
| Volume | 278,188 | |||||
| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.93 +0.04 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.89 | 52 Week High | $2.51 | |||
| Open | $3.86 | 52 Week Low | $0.41 | |||
| Day High | $3.94 | P/E | N/A | |||
| Day Low | $3.86 | EPS | $-0.64 | |||
| Volume | 278,188 | |||||

